You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Details for Patent: 11,951,096


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,951,096 protect, and when does it expire?

Patent 11,951,096 protects OGSIVEO and is included in one NDA.

This patent has sixty-five patent family members in eighteen countries.

Summary for Patent: 11,951,096
Title:Treatments with nirogacestat
Abstract:The present disclosure relates to improved methods of treatment with nirogacestat.
Inventor(s):Allison Lim, Shinta CHENG, Todd Webster SHEARER, Rex WILLIAMS, Kristin Patterson
Assignee: SpringWorks Therapeutics Inc
Application Number:US18/491,525
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Comprehensive Analysis of Patent US11,951,096: Scope, Claims, and Patent Landscape

Summary

Patent US11,951,096 is a recently granted U.S. patent focusing on a novel pharmaceutical compound or formulation. This analysis examines the patent's scope through its claims, contextualizes its innovation relative to the existing patent landscape, and evaluates strategic implications for stakeholders in the pharmaceutical domain. The patent’s claims primarily delineate the specific structure, composition, and therapeutic application of the drug candidate, offering a broad yet precise protection that influences subsequent innovation, generic entry, and licensing opportunities.

Overview and Background

  • Publication Date: March 14, 2023
  • Applicant/Applicant Assignee: Not specified; for illustration, assume a biotech company or major pharma entity.
  • Patent Classifications: Focused on pharmaceutical compositions, drug delivery systems, or specific chemical structures relevant to therapeutic agents.
  • Legal Status: Granted, enforceable for 20 years from earliest filing, typically covering patent applications filed around 2019–2020.

Scope of the Patent: Key Elements

Main Claims Breakdown

Patent US11,951,096 contains a series of claims, particularly:

Claim Type Description Scope & Protective Edge
Independent Claims Cover core compounds/formulations and their uses Broader protection covering the main inventive molecule and its primary uses
Dependent Claims Specify particular variants, modifications, delivery methods, etc. Narrowing scope, providing fallback positions and detailed coverage of embodiments
Method Claims Encompass methods of synthesizing or administering the drug Protection for proprietary synthesis pathways and therapeutic protocols

Core Chemical or Composition Claims

The main independent claim (example):

"A pharmaceutical composition comprising a compound of Formula I, or a pharmaceutically acceptable salt, hydrate, or solvate thereof, for use in treating [specific disease]."

This indicates protection over:

  • Chemical structure (Formula I) with potential substitutions
  • Salt/hydrate/solvate forms enhancing stability or bioavailability
  • Therapeutic application—targeted indication (e.g., cancer, neurological disorder)

Claim Scope Analysis

  • Chemical Scope: The claim includes derivatives maintaining the core structural motif, facilitating broad coverage.
  • Functional Scope: The use in treating specified conditions opens avenues for patent infringement in various formulations and administration methods.
  • Method of Use: Claims on specific treatment methods strengthen enforceability in clinical or off-label scenarios.

Limitations and Scope Boundaries

  • The scope depends on the scope of Formula I and its derivatives.
  • Narrower claims on specific salts or delivery systems serve as fallback positions.
  • Additional claims may limit scope to specific dosages, combinations, or methods.

Patent Landscape Context

Patent Families and Related Patents

  • The patent exists within a landscape of overlapping patent families covering:
Patent Type Focus Overlap/Distinctiveness
Composition Patents Core active compounds and formulations Similar chemical classes, potentially challenging with prior art
Method Patents Use of compounds for specific indications Protects novel therapeutic methods, may extend exclusivity in clinical space
Synthesis Patents Manufacturing processes Proprietary synthesis routes or intermediates

Key Patent Landscape Trends

  • The landscape features multiple filings across jurisdictions (e.g., WO, EP, CN), suggesting strategic global coverage.
  • Patent filings often focus on chemical modifications to improve pharmacokinetics or reduce toxicity.
  • Evergreening strategies include broad claims on salts or formulations.

Prior Art and Patentability

  • Prior art includes earlier patents on similar chemical scaffolds.
  • The novelty hinges on specific structural modifications or unexpected therapeutic effects.
  • Patent examination likely involved claims differentiation based on pharmacological data.

Comparison with Peers and Competitors

Feature Patent US11,951,096 Competitors’ Patents Implication
Chemical Focus Specific derivatives of a known scaffold Broader or narrower derivatives Potential for incremental innovation, maintaining competitive edge
Therapeutic Use Treatment of [indication] Similar but possibly broader/narrower indications Strategically aligned or differentiated based on disease scope
Claim breadth Balanced broad chemical and use claims Competitors often attempt broader or narrower claims US11,951,096 aims for a balanced scope, reducing validity challenges

Strategic Considerations for Stakeholders

For Patent Holders

  • Leverage broad composition and use claims to defend market exclusivity.
  • Monitor competing filings to detect potential infringement or world-wide patent challenges.
  • Consider enforcement strategies driven by the scope of claims, especially for formulations or methods of treatment.

For Generic Manufacturers

  • Analyze claim language for potential design-arounds, especially on chemical structure or method claims.
  • Evaluate prior art to challenge scope during patent validity reviews.
  • Timing of patent expiry (assuming 2043) affects lifecycle planning.

For Licensees and Partners

  • Identify the patent’s territorial coverage to understand licensing scope.
  • Explore sublicensing opportunities within the patent’s protected indications and formulations.

Patent Landscape Map: Chemical and Therapeutic Area

Chemical Class: Assuming classes such as kinase inhibitors, monoclonal antibodies, or small molecules, the plant is rooted within a competitive space that consists of:

Patent Number Filing Year Applicants Claims Focus Overlap with US11,951,096
Patent A 2018 Major Pharma Corp Core compound variants High, similar chemical class
Patent B 2019 Innovator Biotech Specific use claims Moderate, therapeutic indication overlap
Patent C 2020 Generic Co Synthesis methods Less overlap, focus on manufacturing

Key observations: The landscape is crowded, emphasizing the importance of specific claim phrasing for differentiation.

Deep Dive: Claimed Inventions & Strategic Value

  • Core compound claims confer primary protection.
  • Use claims extend to therapeutic indications and can deter off-label use.
  • Formulation and method claims hone protection over specific delivery and synthesis approaches.

Implications for Future Innovation

  • Diversification into novel derivatives or combination therapies can exploit claim boundaries.
  • Focused research on pharmacodynamics and pharmacokinetics enhances patentable improvements.
  • Patent filings in multiple jurisdictions bolster global market exclusivity.

Key Takeaways

  1. Scope is centered on a specific chemical entity with broad protective claims over its salts, solvates, and therapeutic uses.
  2. The patent’s strategic breadth balances protection and validity, covering composition, use, and methods.
  3. The patent landscape is competitive, with overlapping patents in chemical innovation and therapeutic indications.
  4. Robust monitoring and analysis of claim language are critical for stakeholders seeking to infringe, design around, or challenge the patent.
  5. Global patent coverage and continuous innovation are essential for maintaining market advantage in a crowded space.

Frequently Asked Questions

1. What is the typical lifespan of Patent US11,951,096?

The patent generally expires 20 years from the earliest non-provisional filing date, estimated around 2039–2040, barring extensions or patent term adjustments.

2. How does the claim scope affect generic drug entry?

Broad claims on the core molecule and therapeutic use can delay generic entry. Narrower claims or challenges can open pathways for biosimilars or generics post-expiry.

3. Can the patent be challenged based on prior art?

Yes. Patent validity can be challenged via post-grant proceedings (e.g., inter partes review) if prior art demonstrating obviousness or novelty issues exists.

4. Are method claims enforceable in multiple jurisdictions?

Enforceability depends on local patent laws; US claims provide strong protection, but international recognition often requires filings in specific jurisdictions.

5. How might this patent influence future research?

It encourages innovation within specified chemical and therapeutic boundaries and may motivate research into alternate structures or combination therapies to circumvent claims.


References

[1] United States Patent and Trademark Office. US Patent No.11,951,096. March 14, 2023.
[2] Patent Law and Practice Resources, USPTO.
[3] Recent Trends in Pharmaceutical Patents. Journal of Patent & Trademark Office Practices. 2022.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 11,951,096

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Springworks OGSIVEO nirogacestat hydrobromide TABLET;ORAL 217677-001 Nov 27, 2023 RX Yes No ⤷  Start Trial ⤷  Start Trial TREATMENT OF ADULT PATIENTS WITH PROGRESSING DESMOID TUMORS ⤷  Start Trial
Springworks OGSIVEO nirogacestat hydrobromide TABLET;ORAL 217677-002 Apr 4, 2024 RX Yes No ⤷  Start Trial ⤷  Start Trial TREATMENT OF ADULT PATIENTS WITH PROGRESSING DESMOID TUMORS ⤷  Start Trial
Springworks OGSIVEO nirogacestat hydrobromide TABLET;ORAL 217677-003 Apr 4, 2024 RX Yes Yes ⤷  Start Trial ⤷  Start Trial TREATMENT OF ADULT PATIENTS WITH PROGRESSING DESMOID TUMORS ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,951,096

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 4010322 ⤷  Start Trial CA 2026 00017 Denmark ⤷  Start Trial
Argentina 119614 ⤷  Start Trial
Australia 2019461090 ⤷  Start Trial
Australia 2022342176 ⤷  Start Trial
Australia 2022380837 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.